Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBRN | 31.39 | 1.09 | +3.61% |
| iShares Neuroscience and Healthcare ETF | |||
| XITK | 178.11 | 1.61 | +0.91% |
| State Street® SPDR® FctSt Innvtv TechETF | |||
| MLPA | 48.94 | 0.32 | +0.66% |
| Global X MLP ETF | |||
| RND | 30.62 | N/A | N/A |
| First Trust Bloomberg R&D Leaders ETF | |||
| ARDC | 13.44 | -0.06 | -0.44% |
| Ares Dynamic Credit Allocation Fund | |||
A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.
| Ticker / NAME | Correlation To ROQAF | 1D Price Change % | ||
|---|---|---|---|---|
| ROQAF | 100% | N/A | ||
| GNTA - ROQAF | 36% Loosely correlated | -2.07% | ||
| CRBP - ROQAF | 22% Poorly correlated | +3.79% | ||
| SVRA - ROQAF | 21% Poorly correlated | +8.43% | ||
| SKYE - ROQAF | 21% Poorly correlated | +9.91% | ||
| SNTI - ROQAF | 6% Poorly correlated | +4.76% | ||
More | ||||